Korro Bio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	505	384	136	178	1,189	540
Market Cap Growth	-	182.49%	-23.52%	-85.08%	120.41%	-
Enterprise Value	368	247	83	91	1,013	322
PE Ratio	-4.72	-4.72	-2.34	-2.10	-44.87	-27.26
PS Ratio	-	-	-	12.62	32.16	18.64
PB Ratio	2.97	2.26	-1.37	1.36	6.18	3.23
P/FCF Ratio	-5.11	-5.11	-2.31	-2.25	-22.94	16.28
P/OCF Ratio	-5.70	-5.70	-2.53	-2.33	-26.32	15.77
EV/Sales Ratio	-	-	-	6.45	27.40	11.13
EV/EBITDA Ratio	-3.34	-3.34	-1.53	-1.13	-39.14	-16.34
EV/EBIT Ratio	-3.04	-3.04	-1.43	-1.08	-36.89	-15.69
EV/FCF Ratio	-3.29	-3.29	-1.41	-1.15	-19.54	9.72
Debt / Equity Ratio	0.20	0.20	-0.03	0.35	0.24	-
Debt / EBITDA Ratio	-0.45	-0.45	-0.06	-0.57	-1.78	-
Debt / FCF Ratio	-0.44	-0.44	-0.05	-0.58	-0.89	-
Quick Ratio	8.71	8.71	6.42	11.59	8.34	4.12
Current Ratio	8.87	8.87	6.56	11.79	8.45	4.19
Asset Turnover	0	0	0	0.07	0.16	0.22
Interest Coverage	-	-	-	-229.71	-	-
Return on Equity (ROE)	-106.30%	-106.30%	-121.20%	-54.50%	-14.80%	-34.30%
Return on Assets (ROA)	-72.30%	-72.30%	-44.30%	-39.90%	-11.50%	-14.80%
Return on Capital (ROIC)	-41.62%	-41.62%	61.52%	-47.63%	-11.55%	-12.35%
Earnings Yield	-16.08%	-21.17%	-42.75%	-47.71%	-2.23%	-3.67%
FCF Yield	-14.88%	-19.59%	-43.35%	-44.49%	-4.36%	6.14%
Buyback Yield / Dilution	-499.32%	-499.32%	62.86%	-6.50%	-272.90%	-465.24%
Total Shareholder Return	-499.32%	-499.32%	62.86%	-6.50%	-272.90%	-465.24%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).